Researchers Publish 'Revolutionary' Gene Editing Findings

The new RNA technique has only been tested in bacteria, but if it works in human cells, it could be "revolutionary”, say researchers.
Scientific journal Nature publishes papers on RNA gene-editing technique that builds on CRISPR breakthrough that won 2020 Nobel Prize in Chemistry

A new gene-editing tool promises to be even more powerful than an existing technique that won a Nobel Prize in Chemistry, a recently published pair of papers suggest.

The new ‘bridge-editing’ technique employs a combination of Ribonucleic acid (RNA) – a molecule present in the majority of living organisms and viruses – and a type of enzyme, called a recombinase protein. 

Together, these are capable of specifying not only a target site on the genome to be cut, but also the DNA to be edited. It means that this system can be used to insert, remove or reverse DNA sequences of virtually any length, researchers say. 

This effectively makes the RNA programmable, and allows it to bridge a genetic donor and a target, meaning it could herald a safer and more flexible approach to large-scale chromosome changes.

The findings have been published in two papers in Nature, one of the world’s leading multidisciplinary scientific publications.  

The RNA breakthrough builds on existing, similar gene technology, known as CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats). CRISPR is used by research scientists to selectively modify the DNA of living organisms, and was adapted for use in the laboratory from naturally occurring genome editing systems found in bacteria.

Youtube Placeholder

CRISPR uses enzymes to act as ‘genetic scissors’

CRISPR uses enzymes to act as ‘genetic scissors’, to cut DNA at chosen sites on the genome, after which a cell’s repair mechanisms kicks in, to facilitate DNA repair. 

The CRISPR breakthrough was discovered by Jennifer Doudna, Professor of Biochemistry, Biophysics & Structural Biology at the University of California, Berkeley, and Emmanuelle Charpentier, a French professor and researcher in microbiology, genetics, and biochemistry. The pair won the 2020 Nobel Prize in Chemistry for their work. 

The new RNA technique has only been tested in bacteria, but if it works in human cells, it “could be revolutionary”, Patrick Hsu of the Arc Institute in Palo Alto, California – a co-author of the papers – said in a press briefing.

He added that the RNA technique “has the ability to make genetic changes that are thousands of bases long”. This, he added, “is much larger than is practical with the CRISPR genome-editing system, without breaking DNA”.

The multiple steps of DNA repair that are triggered by CRISPR are unnecessary with the bridge repair system, Hsu pointed out, adding that this makes it a more efficient process. 


Featured Articles

Healthcare Business roundup: Baxter, Sanofi & Eli Lilly

Baxter International to sell kidney care spin-off Vantive; Sanofi's consumer health unit ‘to be separated’; Eli Lilly to buy Morphic Holding for $3.2bn

Trane Technologies Helping US Hospitals Meet Climate Pledge

Christy Fetsch of Trane Technologies explains how the company is helping US hospitals meet White House sustainability pledges for US healthcare provision

Nestlé Health Science Targets Weight Loss Side-Effects

Nestlé Health Science launches nutrition initiative to counteract side effects of weight-loss drugs, including hollowed-out 'Ozempic Face'

Eli Lilly Alzheimer's Drug Kisunla Approved in US by FDA

Medical Devices & Pharma

WEF: Gender Health Gap 'Costs women 75mn years of Life'

Medical Devices & Pharma

Schneider: Swathe of NHS Failing to Measure Sustainability